$0.87—Stale · unknown old
NASDAQ • Last print unknown ago
$0.87—Stale · unknown old
Orphazyme Withdraws European Application For Arimoclomol, Initiates Delisting Of Its ADSs
Orphazyme Calls For Court-Mediated Restructuring, Lays Off 50% Workforce
EMA's Advisory Committee Does Not Back Orphazyme's Arimoclomol Application
Trading Penny Stocks? Top Stock Market News for February 11th, 2022
What's Going On in the Stock Market Today, January 19th, 2022
Orphazyme Tightens FY21 Revenue Outlook
Hot Penny Stocks to Buy Right Now? 3 to Watch Next Week
Orphazyme Stock Gains After FDA Update On Arimoclomol In Rare Neurodegenerative Disorder
ORPH Stock: Why The Price Surged Today